Brain Disease Modalities And Software Market Size, Share and Trends Report 2026 to 2035
Share With :
Brain Disease Modalities And Software Market Size is valued at USD 15.2 Billion in 2025 and is predicted to reach USD 25.66 Billion by the year 2035 at a 5.5% CAGR during the forecast period for 2026 to 2035.
Brain Disease Modalities And Software Market Size, Share & Trends Analysis Report By Product (Brain Imaging Modalities and Brain Analysis Software), By Type of Patients (Adults, Pediatrics and Infants), By End-User, Region And Segment Forecasts, 2026 to 2035.
Brain Disease Modalities And Software Market Key Takeaways:
|
Brain disease modalities are medical imaging techniques that are used to diagnose and monitor brain diseases. Brain disease software is used to analyze the images that are produced by brain disease modalities. Brain disease software can be used to identify and measure abnormalities in the brain, to track changes over time, and to plan treatment.
Conventional imaging methods for diagnosing brain disorders include MRI, CT scans, PET, and a combination of PET and MRI or CT features. While a magnetic field and radio waves are used in magnetic resonance imaging (MRI), a computerised tomography scan (CT) produces multi-angular cross-sectional X-ray images. These imaging methods are utilised to monitor vital processes such as brain oxygenation capacity, blood pressure, traumatic cranial injury, strokes, tumours, and neural activity.
The combined advancements in brain disease modalities and software have transformed the neurological diagnosis and treatment landscape. Through improved imaging technologies and sophisticated software tools, medical professionals can identify brain diseases at earlier stages, understand their underlying mechanisms better, and tailor treatment plans for individual patients. Continued research and integration of emerging technologies promise to drive further progress in neurology and offer new hope for patients with brain disorders.
The medical field's AI advancements, rising demand for safe medical imaging devices during surgeries, and increasing prevalence of neurological disorders are significant market drivers. However, the lack of affordability of non-invasive imaging devices hampers market growth in developing economies like Latin America, the Middle East, and Africa. Consequently, the low- and middle-income populations rely on alternative preliminary methods like blood biomarker tests and cognitive scoring tests for neurological disorder diagnosis. Globally, the shortage of Helium gas adversely affects medical imaging as it is essential for cooling down imaging devices after testing, directly impacting their functionality. Despite a decline in the demand for neuroimaging services, there has been a compensatory need for respiratory imaging techniques and COVID-19 treatment tests.
Brain disease modalities and software market are segmented into three main categories: Patients, Products and End-Users. First Patient Type is again subcategories in Adults, Paediatrics and Infants. Secondly, End-Users are subdivided into Hospitals and Clinics, Ambulatory Surgery Centers, Diagnostic Imaging Centers. The last and third segment is by Products in that Brain Imaging Modalities and Brain Analysis Software are two subdivisions. There are five types of brain imaging modalities PET devices, CT devices, MRI devices, PET-CT, PET-MRI.
Almost all the regions are covered under the global brain disease modalities and software market consisting North America, Europe, Asia-Pacific and rest of the world. Besides North America and Europe being the largest market, other developing countries expect strong growth shortly.
| Report Attribute | Specifications |
| Market Size Value In 2025 | USD 15.2 Billion |
| Revenue Forecast In 2035 | USD 25.66 Billion |
| Growth Rate CAGR | CAGR of 5.5% from 2026 to 2035 |
| Quantitative Units | Representation of revenue in US$ Billion and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2025 |
| Forecast Year | 2026-2035 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Product, By Type of Patients, By End-User |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; South Korea; South East Asia |
| Competitive Landscape | United Imaging Healthcare, Koninklijke Philips N.V., General Electric Company, Canon Inc., Siemens Healthineers AG, Vuno Co., Ltd., Fujifilm Holdings Corporation, Aspect Imaging, IXICO, QMENTA, Cortechs.ai, Quantib, Brainomix, Qure.AI, Imaging Biometrics and A.I., and Analysis, Inc. |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Global Brain disease modalities and software Market by Products
Global Brain disease modalities and software Market by Type of Patients
Global Brain disease modalities and software Market by End-User
Global Brain disease modalities and software Market by Region
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
Competitive Landscape
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.